CureVac N.V. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | Buy/Sell | $591.94 | 4.15% | 1 | $227.24B |
| DHR | Danaher | Outperform |
10
|
$265.80 | Buy/Sell | $260.33 | 2.49% | 4 | $196.87B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.39B |
| MRNA | Moderna | Outperform |
16
|
$132.90 | Buy/Sell | $135.42 | -5.19% | 1 | $50.93B |
| BNTX | BioNTech | Outperform |
12
|
$90.61 | Buy/Sell | $123.75 | 3.24% | 3 | $21.84B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.38 | Buy/Sell | HK$3.96 | -68.98% | 0 | HK$26.30B |
| TWST | Twist Bioscience | Outperform |
4
|
$47.01 | Buy/Sell | $34.00 | -4.28% | 2 | $2.40B |